Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy

Jacob D. Estes, Cavan Reilly, Charles M. Trubey, Courtney V Fletcher, Theodore J. Cory, Michael Piatak, Samuel Russ, Jodi Anderson, Thomas G. Reimann, Robert Star, Anthony Smith, Russell P. Tracy, Anna Berglund, Thomas Schmidt, Vicky Coalter, Elena Chertova, Jeremy Smedley, Ashley T. Haase, Jeffrey D. Lifson, Timothy W. Schacker

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Even with prolonged antiretroviral therapy (ART), many human immunodeficiency virus-infected individuals have <500 CD4+ T cells/μL, and CD4+ T cells in lymphoid tissues remain severely depleted, due in part to fibrosis of the paracortical T-cell zone (TZ) that impairs homeostatic mechanisms required for T-cell survival. We therefore used antifibrotic therapy in simian immunodeficiency virus-infected rhesus macaques to determine whether decreased TZ fibrosis would improve reconstitution of peripheral and lymphoid CD4+ T cells. Treatment with the antifibrotic drug pirfenidone preserved TZ architecture and was associated with significantly larger populations of CD4+ T cells in peripheral blood and lymphoid tissues. Combining pirfenidone with an ART regimen was associated with greater preservation of CD4+ T cells than ART alone and was also associated with higher pirfenidone concentrations. These data support a potential role for antifibrotic drug treatment as adjunctive therapy with ART to improve immune reconstitution.

Original languageEnglish (US)
Pages (from-to)744-754
Number of pages11
JournalJournal of Infectious Diseases
Volume211
Issue number5
DOIs
StatePublished - Jan 1 2015

Fingerprint

Simian Immunodeficiency Virus
Virus Diseases
T-Lymphocytes
Population
Therapeutics
Lymphoid Tissue
Fibrosis
Cell- and Tissue-Based Therapy
Macaca mulatta
Pharmaceutical Preparations
Cell Survival
HIV

Keywords

  • Fibroblastic reticular cell network
  • Fibrosis
  • HIV
  • Immune reconstitution
  • T-cell depletion

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy. / Estes, Jacob D.; Reilly, Cavan; Trubey, Charles M.; Fletcher, Courtney V; Cory, Theodore J.; Piatak, Michael; Russ, Samuel; Anderson, Jodi; Reimann, Thomas G.; Star, Robert; Smith, Anthony; Tracy, Russell P.; Berglund, Anna; Schmidt, Thomas; Coalter, Vicky; Chertova, Elena; Smedley, Jeremy; Haase, Ashley T.; Lifson, Jeffrey D.; Schacker, Timothy W.

In: Journal of Infectious Diseases, Vol. 211, No. 5, 01.01.2015, p. 744-754.

Research output: Contribution to journalArticle

Estes, JD, Reilly, C, Trubey, CM, Fletcher, CV, Cory, TJ, Piatak, M, Russ, S, Anderson, J, Reimann, TG, Star, R, Smith, A, Tracy, RP, Berglund, A, Schmidt, T, Coalter, V, Chertova, E, Smedley, J, Haase, AT, Lifson, JD & Schacker, TW 2015, 'Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy', Journal of Infectious Diseases, vol. 211, no. 5, pp. 744-754. https://doi.org/10.1093/infdis/jiu519
Estes, Jacob D. ; Reilly, Cavan ; Trubey, Charles M. ; Fletcher, Courtney V ; Cory, Theodore J. ; Piatak, Michael ; Russ, Samuel ; Anderson, Jodi ; Reimann, Thomas G. ; Star, Robert ; Smith, Anthony ; Tracy, Russell P. ; Berglund, Anna ; Schmidt, Thomas ; Coalter, Vicky ; Chertova, Elena ; Smedley, Jeremy ; Haase, Ashley T. ; Lifson, Jeffrey D. ; Schacker, Timothy W. / Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy. In: Journal of Infectious Diseases. 2015 ; Vol. 211, No. 5. pp. 744-754.
@article{a362e622f21f4315b7f88c30e071b320,
title = "Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy",
abstract = "Even with prolonged antiretroviral therapy (ART), many human immunodeficiency virus-infected individuals have <500 CD4+ T cells/μL, and CD4+ T cells in lymphoid tissues remain severely depleted, due in part to fibrosis of the paracortical T-cell zone (TZ) that impairs homeostatic mechanisms required for T-cell survival. We therefore used antifibrotic therapy in simian immunodeficiency virus-infected rhesus macaques to determine whether decreased TZ fibrosis would improve reconstitution of peripheral and lymphoid CD4+ T cells. Treatment with the antifibrotic drug pirfenidone preserved TZ architecture and was associated with significantly larger populations of CD4+ T cells in peripheral blood and lymphoid tissues. Combining pirfenidone with an ART regimen was associated with greater preservation of CD4+ T cells than ART alone and was also associated with higher pirfenidone concentrations. These data support a potential role for antifibrotic drug treatment as adjunctive therapy with ART to improve immune reconstitution.",
keywords = "Fibroblastic reticular cell network, Fibrosis, HIV, Immune reconstitution, T-cell depletion",
author = "Estes, {Jacob D.} and Cavan Reilly and Trubey, {Charles M.} and Fletcher, {Courtney V} and Cory, {Theodore J.} and Michael Piatak and Samuel Russ and Jodi Anderson and Reimann, {Thomas G.} and Robert Star and Anthony Smith and Tracy, {Russell P.} and Anna Berglund and Thomas Schmidt and Vicky Coalter and Elena Chertova and Jeremy Smedley and Haase, {Ashley T.} and Lifson, {Jeffrey D.} and Schacker, {Timothy W.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/infdis/jiu519",
language = "English (US)",
volume = "211",
pages = "744--754",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy

AU - Estes, Jacob D.

AU - Reilly, Cavan

AU - Trubey, Charles M.

AU - Fletcher, Courtney V

AU - Cory, Theodore J.

AU - Piatak, Michael

AU - Russ, Samuel

AU - Anderson, Jodi

AU - Reimann, Thomas G.

AU - Star, Robert

AU - Smith, Anthony

AU - Tracy, Russell P.

AU - Berglund, Anna

AU - Schmidt, Thomas

AU - Coalter, Vicky

AU - Chertova, Elena

AU - Smedley, Jeremy

AU - Haase, Ashley T.

AU - Lifson, Jeffrey D.

AU - Schacker, Timothy W.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Even with prolonged antiretroviral therapy (ART), many human immunodeficiency virus-infected individuals have <500 CD4+ T cells/μL, and CD4+ T cells in lymphoid tissues remain severely depleted, due in part to fibrosis of the paracortical T-cell zone (TZ) that impairs homeostatic mechanisms required for T-cell survival. We therefore used antifibrotic therapy in simian immunodeficiency virus-infected rhesus macaques to determine whether decreased TZ fibrosis would improve reconstitution of peripheral and lymphoid CD4+ T cells. Treatment with the antifibrotic drug pirfenidone preserved TZ architecture and was associated with significantly larger populations of CD4+ T cells in peripheral blood and lymphoid tissues. Combining pirfenidone with an ART regimen was associated with greater preservation of CD4+ T cells than ART alone and was also associated with higher pirfenidone concentrations. These data support a potential role for antifibrotic drug treatment as adjunctive therapy with ART to improve immune reconstitution.

AB - Even with prolonged antiretroviral therapy (ART), many human immunodeficiency virus-infected individuals have <500 CD4+ T cells/μL, and CD4+ T cells in lymphoid tissues remain severely depleted, due in part to fibrosis of the paracortical T-cell zone (TZ) that impairs homeostatic mechanisms required for T-cell survival. We therefore used antifibrotic therapy in simian immunodeficiency virus-infected rhesus macaques to determine whether decreased TZ fibrosis would improve reconstitution of peripheral and lymphoid CD4+ T cells. Treatment with the antifibrotic drug pirfenidone preserved TZ architecture and was associated with significantly larger populations of CD4+ T cells in peripheral blood and lymphoid tissues. Combining pirfenidone with an ART regimen was associated with greater preservation of CD4+ T cells than ART alone and was also associated with higher pirfenidone concentrations. These data support a potential role for antifibrotic drug treatment as adjunctive therapy with ART to improve immune reconstitution.

KW - Fibroblastic reticular cell network

KW - Fibrosis

KW - HIV

KW - Immune reconstitution

KW - T-cell depletion

UR - http://www.scopus.com/inward/record.url?scp=84942305035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942305035&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiu519

DO - 10.1093/infdis/jiu519

M3 - Article

C2 - 25246534

AN - SCOPUS:84942305035

VL - 211

SP - 744

EP - 754

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -